Wednesday, 04/09/08
Posted 04/09/08,  09:08 pm ET

(Scroll down to see Jim's comments below)

 
 
Today's date:  Wednesday, 04/09/08

  Dow Jones: 12,527    - 49
  NASDAQ:   2,322    - 26
  S&P 500:   1,354    - 11
 
 
 
 
 
First Segment
 
 
Opening Segment 1 Title: 'From Russia With Love'

.  .  .  .  .

Featured Stock(s): CTC Media, Inc (CTCM)

See CTCM's official website here.

See the Yahoo! Finance profile for CTCM here.



See Opening Segment 2, below...
 
After this segment, you can see Jim's Lightning Round picks here...

 

JJC:    It took them a little while but, with 6% GDP growth, the Russians our giving our recessionary economy a daily pants-ing!... The countries of the Warsaw Pact have surpassed us to become the second-greatest capitalists in the world!... Which is why, tonight, I am recommending CTC Media, Inc (CTCM)...

This is the fourth-largest TV broadcasting company in Russia. They own two entertainment channels... CTC, which targets all viewers, from the ages of Six to 54, but tries to be more focused on younger viewers... They've also got a channel for adult women... for the young demo of 25 to the still-young age of 60... It's called Domashny...

In total, CTCM owns 32 TV stations... but, since they have zero news or political programming, the Russian government doesn't care!...

If you want to view CTCM as a traditional media company, it's got strong ratings, but I don't think we should use the same key metrics to evaluate and up-and-coming second world television powerhouse, that we would use to judge our tired old TV business in America.

No, I think CTCM works because of the growing ad market in Russia.  Advertisements may be migrating from TV to the internet here in America...  God, the Soviets... they're just beginning to figure out how to work the clicker!...

They use TV for half of all advertising dollars that get spent in Russia.  They really haven't started feeling the pain of the web yet, let alone DVR's (digital video recorders, like TIVO)...  Think about it... here in America and throughout the Western World, everyone's pretty media-savvy, right?  We're cynical...  Russians... they've only just started to be exposed to real capitalist advertising... something that's 100% necessary in any fast-growing economy, because how else will Russians know what to buy with their new-found wealth?...

.  .  .  .  .

The consensus estimates were 36% growth in Russian TV advertising... that's the polar opposite of the way things are here...

.  .  .  .  .

CTCM has an 11.8% share of the national audience, just with the two stations I told you about before.  In 2000, Russia was 20th in Europe, when it came to advertising spending...  Now, thanks to Russia's new-found prosperity, it's 6th!

Since there's generally a strong relationship between a healthy, growing economy... which Russia and the former Eastern Bloc has...  and the willingness of advertisers to spend money... 

The Soviet Union may have broken up but, at least when it comes to the airwaves, CTCM seems to be aggressively trying to put things back together...

They bought 60% of the largest TV network in Kazakhstan... Channel 31... It's got a 7% share... where they've taken over management... and re-launched the network this month.  Like Russia, Kazakhstan is brimming with oil wells, and its people just need television, so they can watch the advertisements and know what to buy.

CTCM is launching a TV company in Uzbekistan too, in the 2nd quarter, in order to capture that coveted Uzbek demo...

And maybe the best acquisition yet to come is of DTV... that's the men's entertainment channel in Russia, with a 2% audience share... a deal that should close in the 2nd quarter.  CTCM should be able to aggressively cut costs, as DTV's operating margin is much lower than CTCM's 41% operating margin.  The savings are going to be gigantic.

.  .  .  .  .

This thing is just a really good story...  It's like America 40 years ago.

CTCM brings DTV in line with other channels.  I also think that this post-Soviet is ridiculously underpriced...  Get this...

I sat down all day, trying to figure out what stocks in this country have 30% long-term growth, other than Potash (POT) and Mosaic (MOS)...

CTCM has a 30% long-term growth rate... something that's increasingly-rare in our diseased economy... and it trades at a mere 18x expected 2008 earnings.

I believe this stock - like many in the region - is getting a discount, because too many people still think of Russia, and its neighbors, as broken second-world countries.   I call it the Brezhnev discount...

I don't think that will last, as people come to realize that the former Soviet Union and its satellite states, are growing... and a pure-play on ad spending on Russia and its neighbors, like CTCM is a great buy...

.  .  .  .  .

The Bottom Line!:      The Russian stocks are coming... and I think CTC Media, Inc (CTCM) is a great play, a super-cheap way to play the rise of late-stage advertising capitalism in the great former Soviet Union.


[See Jim's 2nd Opening Segment stock picks below... ]

 

 

 



See all of tonight's stocks' latest quotes on Yahoo! Finance



Most popular
investing books ordered:
(click any book to see at Amazon.com)

 
 
 
 
 
 
 
 

 

 

 

 

 

 

 
 

 

 


We need your help!
If you find our service valuable, your donation is critically helpful to support
our operating costs and is MUCH appreciated!
(click below to donate)

We are serving thousands of new visitors every day and our costs are growing as well.  Thank you for your support & generosity!


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
 
 
   
 

Stock Snapshots - Includes all stocks mentioned above

 

 

 

Jim
Cramer's
rating on
this stock

STOCK
SYMBOL

Closing
price
that
day

Opening
price
next
day

Full Company Name/Comments
(see comments above for each)

CTCM

29.00

na

CTC Media, Inc (CTCM)


 

       

 


Mutual-Fund-Holdings.com
NEW RESOURCE!  See Ken Heebner's CGM Focus Fund
Top 25 holdings - The No. 3 Top-Performing Mutual Fund in 2007


 
 
Second Segment
 
 
Final Segment 1 Title: 'No Stock Left Behind'

.  .  .  .  .

Featured Stock(s): Merck (MRK)

See MRK's official website here.

See the Yahoo! Finance profile for MRK here.

 
After this segment, you can see Jim's Lightning Round picks here...

 

JJC:    I've got another "Ketchup Stock" for you tonight...

Ketchup Stocks are stocks that have fallen behind the rest of their cohort...  Remember, 50% of a stock's performance is the sector.  You get the right sector, and something plays catch up... well, I've got to tell you, it works...

I believe these...  plays should make great stocks to own.  They also give me a little certainty because I know, if the sector's working well, it's only a matter of time...

Today, we're playing catch up with a stock I have not recommended on air ever...  We're playing catch up with Merck (MRK)...

This MRK has been taken out and shot... it's had it's head chopped off... and that's all since the results of the enhanced study came out...  This was the study that talked about Vytorin and Zetia... the two cholesterol drugs that MRK markets in a joint venture with Cramer fave, Schering-Plough (SGP*)...

This purported to show that they're no more effective than earlier, much less expensive, off-patent drugs.  It kind of made you feel like, if you're prescribing it, you're an idiot... and, if you're taking it, you're a moron... 

It wasn't good news...  but I believe MRK's been way too beaten down.  I also don't believe that characterization... of any of it.   I think the stock and the drugs are ready to come back...

.  .  .  .  .

Since the initial reports of the study came out... you're going to listen to these numbers and you're going to be blown away...  MRK has lost $31 billion in market cap... $31 billion...  that's absurd.   Total sales of Vytorin and Zetia were $5 billion in 2007.  MRK only gets half of that, because it's a joint venture with Schering-Plough...

I mean, c'mon... MRK's down almost 25% for a joint venture that represents 15% of its sales.  The Street's valuing MRK - which is a great American company - as if they never make another penny from Vytorin or Zetia again.

I think that's garbage...

The news hurt, but it didn't even hurt that badly...  And, in the time since the study came out, Vytorin's recovered back to 10.4%, as of April 6th...  Zetia's staying at around 7.6% (as share of prescriptions given)...  but they haven't continued to fall precipitously...  People are still prescribing and taking these drugs, because there's been a series of articles that have come out by FDA-related people, who have said, look, this is a totally legitimate good way to take down bad cholesterol.  Doctors still believe in it.

I regard the whole enhanced study as simply a speed bump for MRK.  And the Street's acting like it just ran into a retaining wall...

Mark my words...  for MRK, estimates are now probably way too low.  That's the only drug company that I can make that assertions, besides Schering-Plough (SGP*)... 

.  .  .  .  .

Now, here's another assertion I'm going to make...

After this decline, Merck (MRK) is now my #1 pick in the Dow Jones Industrial Average... and I am saying right here, right now... that I believe MRK - a drug company - will outperform all the other Dow Jones stocks between today and the end of the year...  I think it's going to outperform all of them...

I believe we'll look back on this period, and we'll say, how did we steal MRK for under $41 a share...

.  .  .  .  .

Why?... 

First, because drug stocks are what you want to own in a recession... They're the classic secular growth companies that earn the same amount, in a good economy or a bad one...  You don't not take Gardisil - the breakthrough vaccine - because you didn't have a good week at your office...

.  .  .  .  .

MRK's the cheapest its been in a long while.  I think it makes a great buy.  It's 11x forward earnings.  This is a premier American company...

I can't beg you to do anything... but the big drop in prices allowed for a big increase in MRK's dividend yield now...  3.7%.  Great dividend... much better than cash, even before taxes, especially if rates stay low, or keep going lower, which is what I expect will happen.

I think that dividend is a pretty good reason to think MRK can play catch up...

.  .  .  .  .

You can't forget about the host of new drugs MRK has in the pipeline... expected to generate $4.6 billion in sales this year... this is a good pipeline...

I don't see how these drugs could not help its stock play catch up...

I'm talking about Gardisil... that's the HPV vaccine;  Januvia... a lot of people are excited about that... that's a Type II diabetes drug; Icentris for HIV;  Zostavax, which is a shingles vaccine for the over-60 demographic; and RotaTeq, which is a vaccine for RotaVirus, for kids... This should be a real blessing for parents... that should mean a whole lot less...diarrhea for kids.

.  .  .  .  .

Gardisil alone could be huge.  It's in the early stages of addressing a worldwide marketing opportunity.  Sales go to states and governments, so that means you're going to be able to charge a lot...   I'm telling you we're early in Gardisil... we're early.

If that's not enough, MRK's also got a $5.1 billion buyback going.  That's what they have left.  It's enough to take out 5.8% of the float.  MRK's average purchase price in November was $57.50  In December, they paid $59...

Okay, they certainly bought high... I can't congratulate them for buying low... but, with the stock under $41...  I've got to believe they'll use that buyback cash to prop it up, or send the stock higher...  The buyback is covered in "Ketchup"...

.  .  .  .  .

If MRK just goes back to its historical valuation, that would send the stock 10 points higher, to $51...  a 25% gain.

I believe the reaction to the enhanced study was totally overblown.  And, as the Street starts to process that it really didn't destroy Vytorin and Zetia... let alone even reduce their scrip share (i.e., share of prescriptions) by very much...  this stock is going to be a huge catch up play... 

.  .  .  .  .

The Bottom Line!:      I don't get to recommend high-quality, American companies, at a big discount, very often...  This is one of them.  I think you want to be in Merck (